Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Belgium

- PMLiVE

Pfizer’s CMO joins board of Tenet

Freda Lewis-Hall to advise healthcare services firm

- PMLiVE

Galderma removed from list of companies compliant to UK Code

Follows breach of pharma standards

- PMLiVE

ABPI names first project director for manufacturing

James Christie joins from Oxford BioMedica

- PMLiVE

Campaigns recognised at German health comms awards

Schmittgall, Pink Carrots and S&H among the winners

UK flag

UK lags behind other countries in use of branded drugs

ABPI claims use of innovative new treatments is lower than international average in seven out of 11 classes

- PMLiVE

Stratified medicines face uptake challenges in the NHS

But 90% of HCPs believe the area will have a positive impact on the health system

- PMLiVE

Pfizer signs $2.85bn immuno-oncology alliance

Will jointly develop Merck KGaA's lead anti-PD-L1 drug

- PMLiVE

Former Vodafone UK comms head joins ABPI

Aileen Thompson appointed director of communications at UK pharma trade body

- PMLiVE

Pfizer gets FDA nod for meningitis vaccine Trumenba

Ahead of Novartis’ rival drug Bexsero

- PMLiVE

FDA votes to keep severe warning on Pfizer’s Chantix

Will not relax anti-smoking drug's side effect warning

- PMLiVE

Generic drugs restricting market growth in Netherlands

GlobalData says Government focus on cheap copies is impacting industry

- PMLiVE

Pfizer’s palbociclib on track for early 2015 launch

Good news for the highly anticipated breast cancer drug

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links